News
-
-
PRESS RELEASE
Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results - Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningf
Jaguar Health, Inc. issued a letter to shareholders regarding the upcoming webcast to review second-quarter earnings and clinical data from the recent phase 3 OnTarget trial of crofelemer for breast and lung cancer patients -
-
PRESS RELEASE
Vascular Therapies Completes Enrollment in the ACCESS 2 Study, a Phase III Multinational Randomized Clinical Trial of the Sirolimus Eluting Collagen Implant (Sirogen) for the Surgical Creation of Arteriovenous Fistula for Hemodialysis Vascular Access
Vascular Therapies completes enrollment in Phase III ACCESS 2 trial to evaluate perivascular sirolimus for AV fistula in kidney disease patients. Topline results expected Q2 2025 -
-
PRESS RELEASE
ChainFEST, the World’s Largest Celebration of Chain Restaurants, Sets New York City Debut
ChainFEST, the iconic food festival celebrating chain restaurants, comes to Randall's Island on Sep 21, 2024, showcasing gourmet dishes and immersive experiences. Cash App Card presale on Aug 8. Festival tickets on sale Aug 9 -
-
PRESS RELEASE
Spectral Capital Corporation (FCCN), Led by Sean Michael Brehm, Launches Quantum Bridge Program to Advance Quantum Computing Innovations
Spectral Capital Corporation launches Quantum Bridge Program to fast-track quantum computing technologies development and commercialization, bridging research and practical applications -
-
